Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Autologous Cell Therapy Market: By Source, By Application, By End User, and Geography
Autologous Cell Therapy Market: By Source, By Application, By End User, and Geography
Autologous Cell Therapy Market size was valued at US$ 5.2 billion in 2023 and is poised to grow at a CAGR of 19.2% from 2024-2030. Owing to the increase in the prevalence of various incurable diseases and it is an effective and safer technology when compared to that of the existing transplantation technologies in the market. Moreover, benefits such as reduction of risks which are associated with bio-incompatibility, disease transmission and immunological reactions drives the growth of the market.
The therapy involves treating a patient's own cells or tissues outside the body before reintroducing them into the donor. Currently, aesthetic and cosmetic dermatology, modern medicine, and orthopaedics all employ this kind of therapy. A number of autologous therapies exist with the goals of promoting wound healing, reducing chronic inflammation, and promoting wound closure. Autologous cell treatment draws on a variety of scientific disciplines and technologies, from virology to cellular and molecular biology. The Autologous blood vessel and artery grafts have also been used for a very long time in heart disease.
Study Period
2024-2030Base Year
2023CAGR
19.2%Largest Market
Asia-PacificFastest Growing Market
North-America
Sedentary lifestyle and poor dietary choices has fuelled the growth of the malignancy across the world. As per American Cancer Society, a million people are suffering from cancer in United States alone. Moreover, rising funds form the government and private organizations support in cell therapy clinical trials and proven effectiveness of products coupled declining prices of stem cell therapies drives the growth of the market.
North America accounted for larger revenue share in global autologous cell therapy market with significant CAGR owing to increased investments for treatment facilities and presence of large number of companies and strong regulatory framework to promote cell therapies and high cost for the therapy in United States drives the growth of the market. Asia Pacific region is expected to be the fastest growing region over the forecast period owing to rising medical tourism to the region and improvements in healthcare infrastructure in countries like India and China.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 5.2 billion |
|
Market CAGR |
19.2% |
|
By Source |
|
|
By Application |
|
|
By End User |
|
Download Free Sample Report
The autologous cell therapy market size was valued at US$ 5.2 billion in 2023 and is poised to grow at a CAGR of 19.2% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Global Autologous Cell Therapy Market Introduction |
| 2.1. Global Autologous Cell Therapy Market Taxonomy |
| 2.2. Global Autologous Cell Therapy Market Definitions |
| 2.2.1. Source |
| 2.2.2. Application |
| 2.2.3. End User |
| 2.2.4. Region |
| 3. Global Autologous Cell Therapy Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Current Trends |
| 3.5. Global Autologous Cell Therapy Market Dynamic Factors - Impact Analysis |
| 3.6. Mergers, Acquisitions, and Collaborations |
| 4. Global Autologous Cell Therapy Market Analysis, 2019-2023 and Forecast, 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Autologous Cell Therapy Market, By Source, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1. Bone Marrow |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Epidermis |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Mesenchymal Stem Cells |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Hematopoietic Stem Cells |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Chondrocytes |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Autologous Cell Therapy Market, By Application, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1. Cancer |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Neurodegenerative Diseases |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Wound Healing |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Orthopedic |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Cardiovascular Diseases |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Autoimmune Diseases |
| 6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7. Global Autologous Cell Therapy Market, By End User, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1. Hospitals and Clinics |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Academic and Research Institutes |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Autologous Cell Therapy Market Forecast, By Region, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. MEA |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, and Country, 2024-2030 |
| 9. North America Autologous Cell Therapy Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.1. Source Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Bone Marrow |
| 9.1.2. Epidermis |
| 9.1.3. Mesenchymal Stem Cells |
| 9.1.4. Hematopoietic Stem Cells |
| 9.1.5. Chondrocytes |
| 9.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Cancer |
| 9.2.2. Neurodegenerative Diseases |
| 9.2.3. Wound Healing |
| 9.2.4. Orthopedic |
| 9.2.5. Cardiovascular Diseases |
| 9.2.6. Autoimmune Diseases |
| 9.2.7. Others |
| 9.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Hospitals and Clinics |
| 9.3.2. Academic and Research Institutes |
| 9.3.3. Others |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. United States |
| 9.4.2. Canada |
| 9.5. North America Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027 |
| 9.6. North America Autologous Cell Therapy Market Dynamics Trends |
| 10. Europe Autologous Cell Therapy Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 10.1. Source Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Bone Marrow |
| 10.1.2. Epidermis |
| 10.1.3. Mesenchymal Stem Cells |
| 10.1.4. Hematopoietic Stem Cells |
| 10.1.5. Chondrocytes |
| 10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Cancer |
| 10.2.2. Neurodegenerative Diseases |
| 10.2.3. Wound Healing |
| 10.2.4. Orthopedic |
| 10.2.5. Cardiovascular Diseases |
| 10.2.6. Autoimmune Diseases |
| 10.2.7. Others |
| 10.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Hospitals and Clinics |
| 10.3.2. Academic and Research Institutes |
| 10.3.3. Others |
| 10.4. Country Level Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. UK |
| 10.4.2. Germany |
| 10.4.3. France |
| 10.4.4. Italy |
| 10.4.5. Spain |
| 10.4.6. Rest of Europe |
| 10.5. Europe Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027 |
| 10.6. Europe Autologous Cell Therapy Market Dynamics Trends |
| 11. Asia Pacific Autologous Cell Therapy Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 11.1. Source Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Bone Marrow |
| 11.1.2. Epidermis |
| 11.1.3. Mesenchymal Stem Cells |
| 11.1.4. Hematopoietic Stem Cells |
| 11.1.5. Chondrocytes |
| 11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Cancer |
| 11.2.2. Neurodegenerative Diseases |
| 11.2.3. Wound Healing |
| 11.2.4. Orthopedic |
| 11.2.5. Cardiovascular Diseases |
| 11.2.6. Autoimmune Diseases |
| 11.2.7. Others |
| 11.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Hospitals and Clinics |
| 11.3.2. Academic and Research Institutes |
| 11.3.3. Others |
| 11.4. Country Level Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. China |
| 11.4.2. India |
| 11.4.3. ANZ |
| 11.4.4. Japan |
| 11.4.5. Rest of APAC |
| 11.5. Asia Pacific Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027 |
| 11.6. Asia Pacific Autologous Cell Therapy Market Dynamics Trends |
| 12. MEA Autologous Cell Therapy Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 12.1. Source Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Bone Marrow |
| 12.1.2. Epidermis |
| 12.1.3. Mesenchymal Stem Cells |
| 12.1.4. Hematopoietic Stem Cells |
| 12.1.5. Chondrocytes |
| 12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Cancer |
| 12.2.2. Neurodegenerative Diseases |
| 12.2.3. Wound Healing |
| 12.2.4. Orthopedic |
| 12.2.5. Cardiovascular Diseases |
| 12.2.6. Autoimmune Diseases |
| 12.2.7. Others |
| 12.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Hospitals and Clinics |
| 12.3.2. Academic and Research Institutes |
| 12.3.3. Others |
| 12.4. Country Level Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. GCC Countries |
| 12.4.2. South Africa |
| 12.4.3. Rest of MEA |
| 12.5. MEA Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027 |
| 12.6. MEA Autologous Cell Therapy Market Dynamics Trends |
| 13. Latin America Autologous Cell Therapy Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 13.1. Source Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Bone Marrow |
| 13.1.2. Epidermis |
| 13.1.3. Mesenchymal Stem Cells |
| 13.1.4. Hematopoietic Stem Cells |
| 13.1.5. Chondrocytes |
| 13.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Cancer |
| 13.2.2. Neurodegenerative Diseases |
| 13.2.3. Wound Healing |
| 13.2.4. Orthopedic |
| 13.2.5. Cardiovascular Diseases |
| 13.2.6. Autoimmune Diseases |
| 13.2.7. Others |
| 13.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Hospitals and Clinics |
| 13.3.2. Academic and Research Institutes |
| 13.3.3. Others |
| 13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Brazil |
| 13.4.2. Mexico |
| 13.4.3. Argentina |
| 13.4.4. Rest of LA |
| 13.5. Latin America Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027 |
| 13.6. Latin America Autologous Cell Therapy Market Dynamics Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Brainstorm Cell Therapeutics |
| 14.2.2. Vericel Corporation |
| 14.2.3. Holostem Advanced Therapies |
| 14.2.4. Osiris Therapeutics |
| 14.2.5. Opexa Therapeutics |
| 14.2.6. BioTime Inc. |
| 14.2.7. Phamicell Co. Inc. |
| 14.2.8. Sangamo Therapeutics |
| 14.2.9. Calimmune, Inc. |
| 14.2.10. Bayer, Inc. |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.